ARS Pharmaceuticals, Inc. — DEF 14A Filings
5 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by ARS Pharmaceuticals, Inc. (SPRY), sorted by most recent first. Each row links to the full filing on EdgarLookup. ARS Pharmaceuticals, Inc. has filed 5 DEF 14A documents with the SEC since 2016. To view all SEC filings by ARS Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-Q
10-Q/A
144
144/A
3
3/A
4
4/A
424B4
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DEFM14A
DRS
EFFECT
PREM14A
PRER14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEF 14A | 0000950170-25-060075 | Apr 29, 2025 | Jun 25, 2025 |
| DEF 14A | DEF 14A | 0000950170-24-049071 | Apr 26, 2024 | Jun 20, 2024 |
| DEF 14A | DEF 14A | 0001193125-23-130534 | May 1, 2023 | Jun 27, 2023 |
| DEF 14A | DEF 14A | 0001193125-22-127830 | Apr 28, 2022 | Jun 10, 2022 |
| DEF 14A | DEF 14A | 0001193125-21-126673 | Apr 22, 2021 | Jun 4, 2021 |